Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

By Knudsen L.B.   Pridal L.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 429-435

Elsevier

Access to resources Recommend Favorite

Effect of the Meglitinide Analog S214o3 on Cationic Fluxes and Insulin Release in Perifused Rat Pancreatic Islets Exposed to a High Concentration of D-Glucose

By Louchami K.   Jijakli H.   Malaisse W.J.  

Pharmacological Research, Vol. 40, Iss. 3, 1999-09 ,pp. : 297-300

Academic Press

Access to resources Recommend Favorite

Antazoline increases insulin secretion and improves glucose tolerance in rats and dogs

By Berdeu D.   Puech R.   Ribes G.   Loubatieres-Mariani M.-M.   Bertrand G.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 233-239

Elsevier

Access to resources Recommend Favorite

Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca 2+ -dependent exocytosis in pancreatic - and -cells

By Hoy M.   Olsen H.L.   Andersen H.S.   Bokvist K.   Buschard K.   Hansen J.   Jacobsen P.   Petersen J.S.   Rorsman P.   Gromada J.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

1,5-Anhydro-d-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice

By Ahren B.   Holst J.J.   Yu S.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 219-225

Elsevier

Access to resources Recommend Favorite